Step up to Prevention : A Nurse Practitioner Guided Cervical Cancer Prevention Intervention
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Human Papilloma Virus (HPV) Vaccine #1 Acceptance
研究概览
简要总结
The project is a clinical behavioral research project based at University of Pennsylvania. The goal of this research is to design a brief clinic-based, Nurse Practitioner-guided, and theory-based health promotion intervention to enhance cervical cancer prevention among young women ages 18-26 living in economically disadvantaged urban communities. The investigators will evaluate the intervention for feasibility, acceptability and preliminary efficacy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 26 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Age 18-26 years
- •Not yet received the HPV vaccine
- •Speak, read, and understand 5th grade level of English;
- •Had vaginal sex with a male partner in the past 2 months.
排除标准
- •Currently pregnant and/or plan to be pregnant in next 6 months
研究组 & 干预措施
Step Up to Prevention: knowledge
Participant receives an individual computer-delivered information session and participant is offered the HPV vaccine only by their nurse practitioner in clinic.
干预措施: Step Up to Prevention: knowledge (Behavioral)
Step Up to Prevention:belief
Participant receives a one-on-one tailored educational session with a trained study team member and participant is offered the HPV vaccine only by their nurse practitioner in clinic.
干预措施: Step Up to Prevention:belief (Behavioral)
Step up to Prevention
Participant receives both the knowledge session and the tailored belief sessions and the participant is offered the HPV vaccine only by their nurse practitioner in clinic. This combined intervention is call Step Up to Prevention.
干预措施: Step Up to Prevention (Behavioral)
Offered HPV vaccine only
Participant is offered the HPV vaccine only by their nurse practitioner in clinic.
干预措施: Offered HPV vaccine only (Behavioral)
结局指标
主要结局
Human Papilloma Virus (HPV) Vaccine #1 Acceptance
时间窗: For each participant, at end of first study visit. Will assess until all subjects enrolled in study.
次要结局
未报告次要终点